Biotech · Private company · Princeton, NJ, US
Optimeos Life Sciences, Inc.
Track this companyFree. Adds Optimeos Life Sciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- In vivo targeted delivery of nucleic acids to hematopoietic stem cells for treating primary immunodeficienciesFiscal year 2026 · $300KNIH RePORTER 5R43AI188970-02 · fetched Nov 12, 2026
- In vivo targeted delivery of nucleic acids to hematopoietic stem cells for treating primary immunodeficienciesFiscal year 2025 · $300KNIH RePORTER 1R43AI188970-01A1 · fetched Nov 12, 2026
- Targeted delivery of nucleic acid formulations for in vivo CAR-Treg generationFiscal year 2024 · $300KNIH RePORTER 1R43AI177159-01A1 · fetched Nov 12, 2026